The pharmaceutical landscape is undergoing rapid transformation, driven by evolving regulatory frameworks, new payer policy introductions/ shifts, and significant updates to the existing pricing/ market access frameworks. These dynamics are poised to reshape regulatory, pricing and market access (P&MA) strategies for pharmaceutical companies, influencing both the launch of new products and the optimisation of their existing and planned portfolios.  

Our dedicated Global Policy Tracker, accompanying In the Loop newsletter and series of blogs aptly titled, Navigating the Waves, are designed to keep the stakeholders informed and empowered to navigate this complex dynamically evolving environment.